Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway.
about
Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-κB and MAPK/ERK mediated YB-1 activity in A2780/T cellsOroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinomaBM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin.Overview of Oroxylin A: A Promising Flavonoid Compound.Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
P2860
Q27335381-9A032A01-CB77-414B-B6B2-CC21F03B72A3Q28535383-5968E483-22C3-43EF-BA60-AE1CA598A29CQ35568870-85C22B91-54B6-4583-AEE0-E56803791A6BQ36545246-29410430-3781-4748-9989-A79D98A6AEFAQ37269332-2BEEAD8B-7E40-43D3-927E-56085C579BA7Q38931197-6CD1D757-3F11-4A74-86B2-794E60EF5A6FQ39011429-6ACE5621-553F-424C-9DAE-83F8CAA6A563Q39211391-50767AA4-FDA1-4A68-9CA3-9A55FDFE0CA4Q43084566-25500329-0E19-4FC2-81C1-FD37BA3CC0ECQ45349809-173B7DCC-4F5B-4FA6-8EF4-DE0D10AE20C7Q46791877-7A701644-9207-4BD1-AC19-F7DD18460530
P2860
Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oroxylin A reverses multi-drug ...... iting NF-κB signaling pathway.
@en
Oroxylin A reverses multi-drug ...... iting NF-κB signaling pathway.
@nl
type
label
Oroxylin A reverses multi-drug ...... iting NF-κB signaling pathway.
@en
Oroxylin A reverses multi-drug ...... iting NF-κB signaling pathway.
@nl
prefLabel
Oroxylin A reverses multi-drug ...... iting NF-κB signaling pathway.
@en
Oroxylin A reverses multi-drug ...... iting NF-κB signaling pathway.
@nl
P2093
P2860
P356
P1476
Oroxylin A reverses multi-drug ...... biting NF-κB signaling pathway
@en
P2093
Hui-Ying Yang
Qi-Dong You
P2860
P304
P356
10.1002/MC.20789
P577
2011-05-06T00:00:00Z